Tridolgosir
AlkaPlorer ID: AK002831
Synonym: None
IUPAC Name: (1S,2R,8R,8aR)-1,2,3,5,6,7,8,8a-octahydroindolizine-1,2,8-triol
Structure
SMILES: O[C@H]1[C@H]2[C@H](O)CCCN2C[C@H]1O
InChI: InChI=1S/C8H15NO3/c10-5-2-1-3-9-4-6(11)8(12)7(5)9/h5-8,10-12H,1-4H2/t5-,6-,7-,8-/m1/s1
InChIKey: FXUAIOOAOAVCGD-WCTZXXKLSA-N
Reference
PubChem CID: 51683
LOTUS: LTS0098111
SuperNatural Ⅲ: SN0098374-03
NPASS: NPC233034
data_source: manually
Source
| Species | Genus | Family | Order | Class | Phylum | Kingdom | Domain |
|---|
Properties Information
Molecule Weight: 173.212
TPSA?: 63.93000000000001
MolLogP?: -1.4529
Number of H-Donors: 3
Number of H-Acceptors: 4
RingCount: 2
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Bacteroides thetaiotaomicron | GH92 alpha-mannosidase | Ki | 5000.0 | nM | 10.1038/nchembio.278 |
| Bacteroides thetaiotaomicron | GH92 alpha-mannosidase | Ki | 14000.0 | nM | 10.1038/nchembio.278 |
| Drosophila melanogaster | Mannosyl-oligosaccharide alpha-1,2-mannosidase isoform B | IC50 | 5.0 | nM | 10.1016/j.ejmech.2011.01.012 |
| Drosophila melanogaster | Mannosyl-oligosaccharide alpha-1,2-mannosidase isoform B | Ki | 3.0 | nM | 10.1016/j.ejmech.2011.01.012 |
| Electrophorus electricus | Acetylcholinesterase | Inhibition | 5.09 | % | 10.1016/j.bmc.2012.09.040 |
| Equus caballus | Cholinesterase | Inhibition | -2.04 | % | 10.1016/j.bmc.2012.09.040 |
| Glycine max | Alpha-mannosidase | IC50 | 400.0 | nM | 10.1021/jm0409019 |
| Homo sapiens | 786-0 | GI50 | 100000.0 | nM | None |
| Homo sapiens | A498 | GI50 | 100000.0 | nM | None |
| Homo sapiens | A549 | GI50 | 100000.0 | nM | None |
| Homo sapiens | ACHN | GI50 | 100000.0 | nM | None |
| Homo sapiens | CAKI-1 | GI50 | 100000.0 | nM | None |
| Homo sapiens | CCRF-CEM | GI50 | 85310.01 | nM | None |
| Homo sapiens | COLO 205 | GI50 | 100000.0 | nM | None |
| Homo sapiens | DLD-1 | GI50 | 100000.0 | nM | None |
| Homo sapiens | DMS-114 | GI50 | 100000.0 | nM | None |
| Homo sapiens | DMS-273 | GI50 | 100000.0 | nM | None |
| Homo sapiens | EKVX | GI50 | 100000.0 | nM | None |
| Homo sapiens | HCC 2998 | GI50 | 100000.0 | nM | None |
| Homo sapiens | HCT-116 | GI50 | 100000.0 | nM | None |
| Homo sapiens | HCT-15 | GI50 | 100000.0 | nM | None |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -10.91 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -3.14 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | HL-60 | GI50 | 100000.0 | nM | None |
| Homo sapiens | HOP-18 | GI50 | 100000.0 | nM | None |
| Homo sapiens | HOP-62 | GI50 | 100000.0 | nM | None |
| Homo sapiens | HOP-92 | GI50 | 100000.0 | nM | None |
| Homo sapiens | HT-29 | GI50 | 100000.0 | nM | None |
| Homo sapiens | IGROV-1 | GI50 | 100000.0 | nM | None |
| Homo sapiens | J-RT3-T3-5 | Activity | nan | None | 10.1074/jbc.m706923200 |
| Homo sapiens | Jurkat | Activity | nan | None | 10.1074/jbc.m706923200 |
| Homo sapiens | KM12 | GI50 | 100000.0 | nM | None |
| Homo sapiens | KM-20L2 | GI50 | 100000.0 | nM | None |
| Homo sapiens | Linker for activation of T-cells family member 1 | Activity | nan | None | 10.1074/jbc.m706923200 |
| Homo sapiens | LOX IMVI | GI50 | 100000.0 | nM | None |
| Homo sapiens | LXFL 529 | GI50 | 100000.0 | nM | None |
| Homo sapiens | Lysosomal alpha-mannosidase | IC50 | 10.0 | nM | 10.1016/j.bmc.2008.06.021 |
| Homo sapiens | Lysosomal alpha-mannosidase | IC50 | 50.0 | nM | 10.1016/j.bmc.2008.06.021 |
| Homo sapiens | Lysosomal alpha-mannosidase | IC50 | 20000.0 | nM | 10.1016/j.bmc.2008.06.021 |
| Homo sapiens | M14 | GI50 | 100000.0 | nM | None |
| Homo sapiens | M19-MEL | GI50 | 100000.0 | nM | None |
| Homo sapiens | Malme-3M | GI50 | 100000.0 | nM | None |
| Homo sapiens | MOLT-4 | GI50 | 100000.0 | nM | None |
| Homo sapiens | NCI-H226 | GI50 | 100000.0 | nM | None |
| Homo sapiens | NCI-H23 | GI50 | 100000.0 | nM | None |
| Homo sapiens | NCI-H322M | GI50 | 100000.0 | nM | None |
| Homo sapiens | NCI-H460 | GI50 | 100000.0 | nM | None |
| Homo sapiens | NCI-H522 | GI50 | 100000.0 | nM | None |
| Homo sapiens | OVCAR-3 | GI50 | 100000.0 | nM | None |
| Homo sapiens | OVCAR-4 | GI50 | 100000.0 | nM | None |
| Homo sapiens | OVCAR-5 | GI50 | 100000.0 | nM | None |
| Homo sapiens | OVCAR-8 | GI50 | 100000.0 | nM | None |
| Homo sapiens | RPMI-8226 | GI50 | 100000.0 | nM | None |
| Homo sapiens | RXF 393 | GI50 | 100000.0 | nM | None |
| Homo sapiens | RXF 631 | GI50 | 100000.0 | nM | None |
| Homo sapiens | SF-268 | GI50 | 100000.0 | nM | None |
| Homo sapiens | SF-295 | GI50 | 100000.0 | nM | None |
| Homo sapiens | SF-539 | GI50 | 100000.0 | nM | None |
| Homo sapiens | SK-MEL-2 | GI50 | 100000.0 | nM | None |
| Homo sapiens | SK-MEL-28 | GI50 | 100000.0 | nM | None |
| Homo sapiens | SK-MEL-5 | GI50 | 100000.0 | nM | None |
| Homo sapiens | SK-OV-3 | GI50 | 100000.0 | nM | None |
| Homo sapiens | SN12C | GI50 | 100000.0 | nM | None |
| Homo sapiens | SNB-19 | GI50 | 100000.0 | nM | None |
| Homo sapiens | SNB-75 | GI50 | 100000.0 | nM | None |
| Homo sapiens | SNB-78 | GI50 | 100000.0 | nM | None |
| Homo sapiens | SW-620 | GI50 | 100000.0 | nM | None |
| Homo sapiens | TK-10 | GI50 | 100000.0 | nM | None |
| Homo sapiens | Tyrosine-protein kinase LCK | Activity | nan | None | 10.1074/jbc.m706923200 |
| Homo sapiens | Tyrosine-protein kinase ZAP-70 | Activity | nan | None | 10.1074/jbc.m706923200 |
| Homo sapiens | U-251 | GI50 | 100000.0 | nM | None |
| Homo sapiens | UACC-257 | GI50 | 100000.0 | nM | None |
| Homo sapiens | UACC-62 | GI50 | 100000.0 | nM | None |
| Homo sapiens | UO-31 | GI50 | 100000.0 | nM | None |
| Homo sapiens | XF498 | GI50 | 100000.0 | nM | None |
| Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 reverse transcriptase | IC50 | 200.0 | ug.mL-1 | 10.1021/np50073a012 |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 9528.3 | nM | None |
| Rattus norvegicus | Alpha-mannosidase 2C1 | IC50 | 1750.0 | nM | 10.1021/jm00129a011 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 13.48 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -4.47 | % | 10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 0.05 | % | 10.6019/CHEMBL4495565 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (acute) | 10.5 | % | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (animal toxicity known) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (benign tumour) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (granulomatous hepatitis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (mechanism) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (moderate) | 2.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (moderate) | 52.6 | % | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (time to onset) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | No relevant target | Activity | nan | None | 10.1074/jbc.m706923200 |
| None | T-cell | Activity | nan | None | 10.1074/jbc.m706923200 |
| None | Unchecked | Activity | nan | None | 10.1021/np50098a020 |
| None | Unchecked | Activity | nan | None | 10.1074/jbc.m706923200 |
| None | Unchecked | Hepatotoxicity (acute) | 1.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (association with vascular disease) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (choleostasis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (chronic liver disease) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (cirrhosis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (comment) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (cytolytic) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (malignant tumour) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (severe hepatitis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (steatosis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (successful reintroduction) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | IC50 | 11.0 | nM | 10.1016/j.ejmech.2011.01.012 |
| None | Unchecked | IC50 | 40.0 | nM | 10.1016/j.bmc.2008.06.021 |
| None | Unchecked | IC50 | 100.0 | nM | 10.1016/j.bmc.2011.09.046 |
| None | Unchecked | Inhibition | 50.0 | % | 10.1021/np50120a009 |
| None | Unchecked | Ki | 20.0 | nM | 10.1016/j.bmc.2008.06.021 |
| None | Unchecked | Ki | 155.0 | nM | 10.1016/j.bmc.2008.06.021 |
| None | Unchecked | Potency | 25118.9 | nM | None |
